Validation of reference tissue modelling for [C]flumazenil positron emission tomography following head injury.

Objective: [C]Flumazenil ([C]FMZ) positron emission tomography (PET) can be used as a measure of neuronal loss. The purpose of this study was to validate reference tissue kinetic modelling of [C]FMZ PET within a group of patients with head injury. Methods: Following earlier studies, the pons was used as the reference region. PET scans were performed on 16 controls and 11 patients at least 6 months following injury, each of whom also had arterial blood sampling to provide whole blood and metabolite-corrected plasma input functions. Regional non-displaceable binding potentials (BP) were calculated from five reference tissue models and compared to BP from arterial input models. For the patients, the regions included a peri-lesional region of interest (ROI). Results: Total distribution volume of the pons was not significantly different between control and patient groups ( P = 0.24). BP from all the reference tissue approaches correlated well with BP from the plasma input models for both controls ( r = 0.98-1.00; P < 0.001) and patients ( r = 0.99-1.00; P < 0.001). For the peri-lesional regions ( n = 11 ROI values), the correlation was also high ( r = 0.91). Conclusions: These results indicate that reference tissue modelling with the pons as the reference region is valid for [C]FMZ PET in head-injured patients at 6 months following injury within both normal appearing and peri-lesional brain regions. [ABSTRACT FROM AUTHOR]